Interesting point! But of course there are some differences. We have to wait to see if HS-110 + Opdivo results are as good as CAR-T. We have wait to see if they avoid the patient deaths seen with some CAR-T's. We know that the off-the-shelf cost of Heat's drugs are a tiny fraction of the $475,000 cost of CAR-T drugs! There will be a lot of important information released over the next few months IMO!